Simon-Martinez, Cristina
Antoniou, Maria-Paraskevi
Bouthour, Walid
Bavelier, Daphne
Levi, Dennis
Backus, Benjamin T.
Dornbos, Brian
Blaha, James J.
Kropp, Martina
Müller, Henning
Murray, Micah
Thumann, Gabriele
Steffen, Heimo
Matusz, Pawel J.
Article History
Received: 18 January 2023
Accepted: 25 April 2023
First Online: 17 May 2023
Declarations
:
: This study is approved by the Ethical Cantonal Board of Geneva, Switzerland (CCER N° 2021-D0090) and all methods are performed in accordance with the relevant guidelines and regulations. Before entering the study, written informed consent from all parents or caregivers and patients older than 14 years old will be obtained. Additionally, verbal assent will be obtained from participants between 6–14 years old. Through the insurance taken by the HES-SO Valais (sponsor of the study), the participants are insured for possible injuries as a result of their participation in the study.
: Not applicable.
: James Blaha is the CEO and founder of Vivid Vision Inc. Ben Backus is the Chief Science Officer of Vivid Vision Inc. Brian Dornbos is the Chief Operations Officer of Vivid Vision Inc. Vivid Vision Inc. freely provided the licenses to use Vivid Vision Home for the study. Vivid Vision Inc. does not have the ultimate authority on the design, intervention or publication of this study. The other authors declare that they have no competing interests.